今日药学

2021, v.31(01) 65-68

[打印本页] [关闭]
本期目录(Current Issue) | 过刊浏览(Past Issue) | 高级检索(Advanced Search)

1例COVID-19合并抑郁症患者的药物治疗评价与药学监护
Evaluation of Drug Therapy and Pharmaceutical Care in A Patient with COVID-19 and Depression

熊堉;边原;唐曦婷;童荣生;崔小娇;蒋敏;杨志勇;
XIONG Yu;BIAN Yuan;TANG Xiting;TONG Rongsheng;CUI Xiaojiao;JIANG Min;YANG Zhiyong;Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China;School of Medicine,University of Electronic Science and Technology of China;Department of Pharmacy,Ganzi Tibetan autonomous prefecture people's hospital;

摘要(Abstract):

目的为临床药师参与COVID-19合并抑郁症患者的药学监护提供参考。方法:临床药师参与了1例COVID-19合并抑郁症患者的治疗过程,优化治疗方案并提供全程化的药学监护。结果:此例患者在新冠肺炎治疗期间,因病情复杂,合并用药种类较多,在治疗过程中出现癫痫发作,药疹及肝功能异常,临床药师经过药物治疗分析和评价之后,为临床医生提供相应的调整策略,并实施全程化的药学监护。最终,患者感染等症状控制,治愈出院。结论:临床药师能在COVID-19患者治疗的过程中协助临床医师不断优化调整方案,为患者的治疗起到积极的作用。
OBJECTIVE To provide a reference for clinical pharmacists participating in the pharmaceutical monitoring of a COVID-19 patient with depression. METHODS The clinical pharmacist participated in the treatment of a COVID-19 patient with depression,optimized the treatment plan and provided full-course pharmaceutical monitoring. RESULTS During the treatment of COVID-19 in this patient,due to the complicated condition and many types of combined medication,seizures,drug eruptions and abnormal liver function were occurred during the treatment. After the analysis and evaluation of the drug treatment,the clinical pharmacists provided corresponding adjustment strategies for the clinicians and implemented a full-course pharmaceutical supervision.Eventually,infection and other symptoms of the patient were controlled and cured. CONCLUSION Clinical pharmacists can assist clinicians in continuously optimizing and adjusting programs during the treatment of COVID-19 to patients,and play a positive role in the treatment of patients.

关键词(KeyWords): 新型冠状病毒肺炎;抑郁症;临床药师;药物治疗评价;药学监护
COVID-19;depressive disorder;clinical pharmacists;drug treatment evaluation;pharmaceutical care

Abstract:

Keywords:

基金项目(Foundation): 国家临床重点专科建设项目(30305030698);; 四川省省级公益性科研院所基本科研业务专项课题(2018YSKY0017);; 四川省人民医院院级科研基金临床研究及转化项目(2018LY09)

作者(Author): 熊堉;边原;唐曦婷;童荣生;崔小娇;蒋敏;杨志勇;
XIONG Yu;BIAN Yuan;TANG Xiting;TONG Rongsheng;CUI Xiaojiao;JIANG Min;YANG Zhiyong;Personalized Drug Therapy Key Laboratory of Sichuan Province,Department of Pharmacy,Sichuan Academy of Medical Sciences,Sichuan Provincial People's Hospital,Affiliated Hospital of University of Electronic Science and Technology of China;School of Medicine,University of Electronic Science and Technology of China;Department of Pharmacy,Ganzi Tibetan autonomous prefecture people's hospital;

Email:

DOI:

参考文献(References):

扩展功能
本文信息
服务与反馈
本文关键词相关文章
本文作者相关文章
中国知网
分享